Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hyaluronic Acid Filler Migration

NCT: NCT07079397 · ACTIVE_NOT_RECRUITING

NCT IDNCT07079397
StatusACTIVE_NOT_RECRUITING
Start Date2025-12-11
Completion2027-12-01
SponsorErevna Innovations Inc. (OTHER)
First posted
Last updated

Brief Summary

Soft tissue filler injections continue to grow in popularity as a method of facial rejuvenation, including volume restoration and contour enhancement. Many different hyaluronic acid (HA)-based fillers are available on the market and differ in terms of their physical and chemical properties, which results in families of fillers (e.g., Non-Animal Stabilized Hyaluronic Acid - NASHA vs. Optimal Balance Technology - OBT) with different tissue integration patterns. It has been proposed that the properties of fillers significantly influences their tendency to migrate. More specifically, thick fillers may be less prone to migration compared to fluid fillers. However, a detailed knowledge of facial anatomy, safer injection techniques, and careful product selection based on filler qualities may be preventive measures for filler migration. The goal of this study is to describe the short and intermediate-term product distribution/integration patterns of NASHA and OBT-based fillers, and to evaluate the evidence (if any) of filler migration from the intended site of injection.

Frequently Asked Questions

What is Hyaluronic Acid Filler Migration?

Hyaluronic Acid Filler Migration is a clinical trial registered under NCT07079397. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07079397?

The current status of NCT07079397 (Hyaluronic Acid Filler Migration) is: ACTIVE_NOT_RECRUITING.

When did Hyaluronic Acid Filler Migration start?

Hyaluronic Acid Filler Migration started on 2025-12-11.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.